Cryo-ultrasound Versus LASER Therapy on Ankle Sprain in Tennis Players
NCT ID: NCT06766318
Last Updated: 2025-01-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2024-02-09
2024-10-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Therapeutic Low Laser Therapy and Kinesio Taping for Lateral Ankle Sprain
NCT07235943
Comparing VR and Balance Exercises In Rehabilitation of Adolescent Athletes
NCT04592900
Therapeutic Effects of Cryotherapy on Arthrogenic Muscle Inhibition in Patients With Cruciate Ligament Reconstruction
NCT01273649
Multisegmented Foot Motion in Patients With Lateral Ankle Sprains and Chronic Ankle Instability
NCT02697461
Effect of Heel Lift Insole on Kinematics and Kinetics of the Lower Limb and Lumbar Spine Among Healthy Individuals
NCT07047300
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
cryo-ultrasound group (n = 20): received cryo-ultrasound therapy
received cryo-ultrasound therapy combined with conventional physical therapy
group A will receive cryo-ultrasound therapy combined with conventional physical therapy for two months
Cryo-ultrasound therapy combines two therapeutic methods: cryotherapy (using cold) and ultrasound (using sound waves). The ultrasound component provides a therapeutic heating effect, improving blood circulation and tissue flexibility, while the cold component reduces pain and inflammation
Laser group
receive LASER therapy combined with conventional physical therapy
LASER therapy
group B will receive LASER therapy combined with conventional physical therapy.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
group A will receive cryo-ultrasound therapy combined with conventional physical therapy for two months
Cryo-ultrasound therapy combines two therapeutic methods: cryotherapy (using cold) and ultrasound (using sound waves). The ultrasound component provides a therapeutic heating effect, improving blood circulation and tissue flexibility, while the cold component reduces pain and inflammation
LASER therapy
group B will receive LASER therapy combined with conventional physical therapy.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* elite girls;
* semi-professional tennis players;
* I-II grade lateral ankle sprain injury;
* no persistent instability phenomena or chronic sprains;
* acute injury (within 2 weeks from trauma);
* no evidence of bone edema or skin disorder, once the area of intense pain in motion was delimited, the lack of neurological disturbances was investigated and assessed.
Exclusion Criteria
* severe rheumatic diseases and/or collagen diseases;
* athletes who have received any form of local physical therapy and NSAIDs within the last 2 months prior to injury;
* athletes who admit to using steroids;
* any contraindication and/or limitation to the use of a physical agent modality (implantable electrophysiological devices, active neoplasms). Taking medications.
* Athletic adult.
12 Years
16 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
October 6 University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kerolous Ishak Shehata
Assistant professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kerolous Ishak Kelini, PHD
Role: PRINCIPAL_INVESTIGATOR
AL-Zaytoonah University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cairo University
Cairo, , Egypt
Kerolous Ishak Shehata Kelini
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REC/012/005532
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.